[Federal Register Volume 69, Number 197 (Wednesday, October 13, 2004)]
[Notices]
[Page 60884]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-22985]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following Federal Committee meeting.

    Name: Advisory Committee on Immunization Practices (ACIP).
    Times and Dates: 9 a.m.-5:45 p.m., October 27, 2004; 8 a.m.-4:35 
p.m., October 28, 2004.
    Place: Atlanta Marriott Century Center, 2000 Century Boulevard, 
NE., Atlanta, Georgia 30345-3377.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters To Be Discussed: The agenda will include discussions on 
influenza which includes a VFC vote on use of Live Attenuated 
Influenza Vaccine; proposed recommendations for use of quadrivalent 
meningococcal conjugate vaccine (MCV4); recommendations for use of 
Hepatitis A Vaccine; an update on implementation of strategy to 
eliminate Hepatitis B virus transmission; varicella epidemiology and 
future program goals, including consideration of 2 dose varicella 
vaccination; proposal for an evidenced based format for ACIP 
recommendations; consideration of revisions for the Harmonized 
Childhood Immunization schedule; revisions to the 2002 General 
Recommendations; discussion of smallpox vaccine safety; and working 
group and Departmental updates.
    Agenda items are subject to change as priorities dictate.
    Due to programmatic issues that had to be resolved, the Federal 
Register notice is being published less than fifteen days before the 
date of the meeting.
    For Further Information Contact: Demetria Gardner, Epidemiology 
and Surveillance Division, National Immunization Program, CDC, 1600 
Clifton Road, NE, (E-61), Atlanta, Georgia 30333, telephone 404/639-
8096, fax 404/639-8616.
    The Acting Director, Management Analysis and Services Office, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee 
management activities for both the CDC and ATSDR.

    Dated: October 7, 2004.
B. Kathy Skipper,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 04-22985 Filed 10-8-04; 9:19 am]
BILLING CODE 4163-18-P